Seres Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Seres Therapeutics, Inc. (MCRB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 586.61 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-05
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 586.61K shares, a 22.87% increase year-over-year.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 34.37K shares, a 94.66% decline year-over-year.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 546.80K shares, a 93.01% decline from fiscal 2024.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 7.82M shares.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 4.53M shares, a 25.64% increase from fiscal 2021.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 3.60M shares, a 29.27% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 586.61K shares 10-Q · filed 2026-08-05 | 586.61K shares derived: sum of 3 quarters · filed 2026-08-05 | 620.98K shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 586.61K shares 10-Q · filed 2026-05-05 | 586.61K shares derived: sum of 2 quarters · filed 2026-05-05 | 620.98K shares derived: sum of 3 quarters · filed 2026-05-05 | 655.98K shares derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 34.37K shares derived: sum of 2 quarters · filed 2026-03-12 | 69.37K shares derived: sum of 3 quarters · filed 2026-03-12 | 546.80K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 34.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 69.37K shares derived: sum of 2 quarters · filed 2025-11-05 | 546.80K shares 10-Q · filed 2025-11-05 | 546.80K shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 35.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 512.43K shares 10-Q · filed 2025-08-06 | 512.43K shares derived: sum of 3 quarters · filed 2025-08-06 | 1.16M shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 477.43K shares 10-Q · filed 2025-05-07 | 477.43K shares derived: sum of 2 quarters · filed 2025-05-07 | 1.12M shares derived: sum of 3 quarters · filed 2025-05-07 | 1.55M shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 643.91K shares derived: sum of 2 quarters · filed 2025-03-13 | 1.07M shares derived: sum of 3 quarters · filed 2025-03-13 | 7.82M shares 10-K · filed 2025-03-13 |
| 2024-09-30 | 643.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 1.07M shares derived: sum of 2 quarters · filed 2024-11-13 | 7.82M shares 10-Q · filed 2024-11-13 | 7.82M shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 430.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 7.17M shares 10-Q · filed 2024-08-13 | 7.18M shares derived: sum of 3 quarters · filed 2024-08-15 | 7.25M shares derived: sum of 4 quarters · filed 2024-08-15 |
| 2024-03-31 | 6.74M shares 10-Q · filed 2024-05-08 | 6.74M shares derived: sum of 2 quarters · filed 2024-08-15 | 6.82M shares derived: sum of 3 quarters · filed 2024-08-15 | 7.13M shares derived: sum of 4 quarters · filed 2024-08-15 |
| 2023-12-31 | 1.50K shares derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-15 | 78.01K shares derived: sum of 2 quarters · filed 2024-08-15 | 389.71K shares derived: sum of 3 quarters · filed 2024-08-15 | 2.51M shares 8-K · filed 2024-08-15 |
| 2023-09-30 | 76.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 388.21K shares derived: sum of 2 quarters · filed 2023-11-02 | 2.51M shares 10-Q · filed 2023-11-02 | 2.64M shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 311.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 2.43M shares 10-Q · filed 2023-08-08 | 2.57M shares derived: sum of 3 quarters · filed 2023-08-08 | 2.80M shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 2.12M shares 10-Q · filed 2023-05-09 | 2.26M shares derived: sum of 2 quarters · filed 2023-05-09 | 2.48M shares derived: sum of 3 quarters · filed 2023-05-09 | 3.01M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 136.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 365.90K shares derived: sum of 2 quarters · filed 2023-03-07 | 888.90K shares derived: sum of 3 quarters · filed 2023-03-07 | 4.53M shares 10-K · filed 2023-03-07 |
| 2022-09-30 | 229.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 752.20K shares derived: sum of 2 quarters · filed 2022-11-02 | 4.39M shares 10-Q · filed 2022-11-02 | 5.17M shares derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-06-30 | 523.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | 4.16M shares 10-Q · filed 2022-08-03 | 4.94M shares derived: sum of 3 quarters · filed 2022-08-03 | 5.15M shares derived: sum of 4 quarters · filed 2022-08-03 |
| 2022-03-31 | 3.64M shares 10-Q · filed 2022-05-04 | 4.42M shares derived: sum of 2 quarters · filed 2022-05-04 | 4.63M shares derived: sum of 3 quarters · filed 2022-05-04 | 5.32M shares derived: sum of 4 quarters · filed 2022-05-04 |
| 2021-12-31 | 778.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 986.69K shares derived: sum of 2 quarters · filed 2022-03-01 | 1.68M shares derived: sum of 3 quarters · filed 2022-03-01 | 3.60M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 208.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 901.02K shares derived: sum of 2 quarters · filed 2021-11-10 | 2.83M shares 10-Q · filed 2021-11-10 | 3.35M shares derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | 692.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 2.62M shares 10-Q · filed 2021-08-03 | 3.14M shares derived: sum of 3 quarters · filed 2021-08-03 | 3.39M shares derived: sum of 4 quarters · filed 2021-08-03 |
| 2021-03-31 | 1.92M shares 10-Q · filed 2021-05-04 | 2.45M shares derived: sum of 2 quarters · filed 2021-05-04 | 2.69M shares derived: sum of 3 quarters · filed 2021-05-04 | 4.06M shares derived: sum of 4 quarters · filed 2021-05-04 |
| 2020-12-31 | 521.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | 770.50K shares derived: sum of 2 quarters · filed 2021-03-02 | 2.14M shares derived: sum of 3 quarters · filed 2021-03-02 | 5.10M shares 10-K · filed 2021-03-02 |
| 2020-09-30 | 249.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 1.62M shares derived: sum of 2 quarters · filed 2020-11-09 | 4.57M shares 10-Q · filed 2020-11-09 | 4.68M shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 1.37M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | 4.32M shares 10-Q · filed 2020-07-28 | 4.44M shares derived: sum of 3 quarters · filed 2020-07-28 | 4.48M shares derived: sum of 4 quarters · filed 2020-07-28 |
| 2020-03-31 | 2.96M shares 10-Q · filed 2020-05-07 | 3.07M shares derived: sum of 2 quarters · filed 2020-05-07 | 3.11M shares derived: sum of 3 quarters · filed 2020-05-07 | 3.27M shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 110.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 151.50K shares derived: sum of 2 quarters · filed 2020-03-02 | 308.60K shares derived: sum of 3 quarters · filed 2020-03-02 | 2.46M shares 10-K · filed 2020-03-02 |
| 2019-09-30 | 41.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 198.10K shares derived: sum of 2 quarters · filed 2019-11-05 | 2.35M shares 10-Q · filed 2019-11-05 | 2.60M shares derived: sum of 4 quarters · filed 2019-11-05 |
| 2019-06-30 | 157.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 2.31M shares 10-Q · filed 2019-08-06 | 2.56M shares derived: sum of 3 quarters · filed 2019-08-06 | 2.65M shares derived: sum of 4 quarters · filed 2019-08-06 |
| 2019-03-31 | 2.15M shares 10-Q · filed 2019-05-02 | 2.40M shares derived: sum of 2 quarters · filed 2019-05-02 | 2.49M shares derived: sum of 3 quarters · filed 2019-05-02 | 2.71M shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-12-31 | 254.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 342.50K shares derived: sum of 2 quarters · filed 2019-03-06 | 563.50K shares derived: sum of 3 quarters · filed 2019-03-06 | 2.07M shares 10-K · filed 2019-03-06 |
| 2018-09-30 | 88.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 309.50K shares derived: sum of 2 quarters · filed 2018-11-08 | 1.82M shares 10-Q · filed 2018-11-08 | 1.87M shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 221.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 1.73M shares 10-Q · filed 2018-08-02 | 1.79M shares derived: sum of 3 quarters · filed 2018-08-02 | 1.87M shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 1.51M shares 10-Q · filed 2018-05-09 | 1.56M shares derived: sum of 2 quarters · filed 2018-05-09 | 1.65M shares derived: sum of 3 quarters · filed 2018-05-09 | 1.97M shares derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | 53.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 139.50K shares derived: sum of 2 quarters · filed 2018-03-08 | 461.50K shares derived: sum of 3 quarters · filed 2018-03-08 | 1.75M shares 10-K · filed 2018-03-08 |
| 2017-09-30 | 86.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 408.50K shares derived: sum of 2 quarters · filed 2017-11-08 | 1.70M shares 10-Q · filed 2017-11-08 | 1.78M shares derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | 322.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 1.61M shares 10-Q · filed 2017-08-03 | 1.69M shares derived: sum of 3 quarters · filed 2017-08-03 | 1.89M shares derived: sum of 4 quarters · filed 2017-08-03 |
| 2017-03-31 | 1.29M shares 10-Q · filed 2017-05-04 | 1.37M shares derived: sum of 2 quarters · filed 2017-05-04 | 1.56M shares derived: sum of 3 quarters · filed 2017-05-04 | 1.99M shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | 79.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 276.50K shares derived: sum of 2 quarters · filed 2017-03-16 | 702.50K shares derived: sum of 3 quarters · filed 2017-03-16 | 1.70M shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 197.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 623.00K shares derived: sum of 2 quarters · filed 2016-11-10 | 1.62M shares 10-Q · filed 2016-11-10 | 1.83M shares derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | 426.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 1.42M shares 10-Q · filed 2016-08-11 | 1.63M shares derived: sum of 3 quarters · filed 2016-08-11 | 1.68M shares derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | 992.63K shares 10-Q · filed 2016-05-16 | 1.20M shares derived: sum of 2 quarters · filed 2016-05-16 | 1.26M shares derived: sum of 3 quarters · filed 2016-05-16 | |
| 2015-12-31 | 210.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 263.50K shares derived: sum of 2 quarters · filed 2016-03-14 | 1.75M shares 10-K · filed 2016-03-14 | |
| 2015-09-30 | 53.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 1.54M shares 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | 1.49M shares 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |